Carreno A. Patel, R. Sharma; State Univ. of New York Downstate Med. Ctr., Brooklyn, NY. Kullar Cho aureus Associated Infection Fattouh, B. Ostrowsky, Y. Guo; Montefiore Med. Ctr., Bronx, NY. K-1635

161 TUESDAY SCIENTIFIC SESSIONS Final Program K-1629 A Randomized Controlled Trial to Evaluate a Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients STOP-NT J. J. Carreno 1,2 , S. L. Davis 1,2 , R. M. Chambers 2 , J. A. Vazquez 2 ; 1 Wayne State Univ. Coll. of Pharmacy, Detroit, MI, 2 Henry Ford Hosp., Detroit, MI. K-1630 Outcomes of Methicillin-Resistant Staphylococcus aureus Bacteremia and Vancomycin Minimum Inhibitory Concentration in Hemodialysis Patients

G. A. Patel, R. Sharma; State Univ. of New York Downstate Med. Ctr., Brooklyn, NY.

K-1631 Efficacy and Safety of Daptomycin DAP in the Treatment of Gram-Positive Infections in Patients with Renal Impairment

R. Kullar

1 , I. McClellan 2 , M. Geriak 3 , G. Sakoulas 3 ; 1 Oregon State Univ. Oregon Hlth. Sci. Univ, Portland, OR, 2 Oregon State Univ., Portland, OR, 3 Sharp Mem. Hosp., San Diego, CA. K-1632 Enterococcal Bloodstream Infection During Neutropenic Fever: Impact of Vancomycin Resistance on Mortality

S. Cho

1 , D. Lee 1 , J. Choi 1 , J. Kwon 2 , S. Kim 3 , S. Choi 1 , S. Park 1 , J. Choi 1 , J. Yoo 1 ; 1 Coll. of Med., The Catholic Univ. of Korea, Seoul, Korea, Republic of, 2 Ilsan Hosp., Goyang-si Gyeonggi-do, Korea, Seoul, Korea, Republic of, 3 Coll. of Med., The Korea Univ. of Korea, Seoul, Korea, Republic of. K-1633 Cost-Effectiveness Analysis of Linezolid LIN, Daptomycin DAP and Vancomycin VAN in Methicillin-Resistant Staphylo- coccus aureus MRSA Complicated Skin and Soft Tissue Infec- tions cSSTI from a Spanish Perspective S. Grau 1 , M. M. Alonso-Socas 2 , J. Rodríguez-Baño 3 , A. Soriano 4 , M. Trikic 5 , M. De Salas-Cansado 5 ; 1 Hosp. del Mar, Barcelona, Spain, 2 Univ. Hosp. of Tenerife, Tenerife, Spain, 3 Hosp. Virgen de la Macarena, Sevilla, Spain, 4 Hosp. Clìnic, Barcelona, Spain, 5 Pfizer, Madrid, Spain. K-1634 Treatment and Outcomes of Patients with Daptomycin Non-Susceptible

S. aureus Associated Infection

N. Fattouh, B. Ostrowsky, Y. Guo; Montefiore Med. Ctr., Bronx, NY. K-1635

Daptomycin DAP Outcomes in Patients Pts with Severe Sepsis Due to Staphylococcal Bacteremia SB with Vancomycin VAN MICs of 2 mgL K. Holloway, K. C. Lamp, H. Anderson, M. J. Yoon; Cubist Pharmaceuticals, Lexington, MA.